Featured Article
A deep-learning platform that takes into account the 3D nature of human tissue can outperform traditional histopathology in predicting the recurrence of prostate cancer from biopsies, research suggests.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
AI Improves Prostate Cancer Recurrence Prediction
A deep-learning platform that takes into account the 3D nature of human tissue can outperform traditional histopathology in predicting the recurrence of prostate cancer from biopsies, research suggests.
Targeting Iron Uptake Shows Promise for Treating Asthma and Other Allergic Diseases
Investigators at the Keck School of Medicine of USC have discovered that iron plays a key role in causing inflammation in the lungs during an allergic asthma attack.
Zenas Nets $200M to Advance mAb for Autoimmune Diseases
Zenas is advancing a portfolio of autoimmune therapeutics for conditions such as IgG4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia.
